Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma

BJU International

Volumn 99, Issue 4, 2007, Pages 821-824

  Klatte, Tobias ^a   Chung, Jinsoo ^a   Leppert, John T ^a   Lam, John S ^a   Pantuck, Allan J ^a   Figlin, Robert A ^a   Belldegrun, Arie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Capsule; Collecting system; Kidney cancer; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; KIDNEY CAPSULE; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY TUBULES, COLLECTING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33947325161     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06729.x     Document Type: Article

References (25)

1. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51: 203-5
2. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-23
3. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168: 2395-400
4. Gelb AB. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 981-6
5. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16: 2261-6
6. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002; 73: 1082-7
7. Tanguay S, Pisters LL, Lawrence DD, Dinney CP. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 1996; 155: 26-9
8. Atzpodien J, Schmitt E, Gertenbach U et al. Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer 2005; 92: 843-6
9. Clark JI, Atkins MB, Urba WJ et al. Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial. J Clin Oncol 2003; 21: 3133-40
10. Messing EM, Manola J, Wilding G et al. Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial. J Clin Oncol 2003; 21: 1214-22
11. American Joint Committee on Cancer. Kidney. AJCC Cancer Staging Manual, 6th edn. New York: Springer, 2002: 323-5
12. Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology 2006; 67: 709-12
13. Palapattu GS, Pantuck AJ, Dorey F, Said JW, Figlin RA, Belldegrun AS. Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies. J Urol 2003; 170: 768-72
14. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55
15. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3
16. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63
17. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-62
18. Gonçalves PD, Srougi M, Dall'oglio MF, Leite KR, Ortiz V, Hering F. Low clinical stage renal cell carcinoma. relevance of microvascular tumor invasion as a prognostic parameter. J Urol 2004; 172: 470-4
19. Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002; 59: 532-7
20. Patard JJ, Dorey FJ, Cindolo L et al. Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol 2004; 172: 2167-71
21. Thomas DH, Verghese A, Kynaston HG, Griffiths DF. Analysis of the prognostic implications of different tumour margin types in renal cell carcinoma. Histopathology 2003; 43: 374-80
22. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000; 163: 1090-5
23. Terrone C, Cracco C, Guercio S et al. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. Eur Urol 2004; 46: 472-6
24. Murphy AM, Gilbert SM, Katz AE et al. Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a). BJU Int 2005; 95: 27-30
25. Siemer S, Lehmann J, Loch A et al. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 2005; 173: 33-7